GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (XSWX:ROG) » Definitions » Median PS Value

Roche Holding AG (XSWX:ROG) Median PS Value

: CHF329.89 (As of Today)
View and export this data going back to 2001. Start your Free Trial

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Roche Holding AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was CHF75.176. Roche Holding AG's 10-Year median PS Ratio is 4.3882. Therefore, the Median PS Value for today is CHF329.89.

As of today (2024-04-19), Roche Holding AG's share price is CHF220.00. Roche Holding AG's Median PS Value is CHF329.89. Therefore, Roche Holding AG's Price to Median PS Value for today is 0.67.

The historical rank and industry rank for Roche Holding AG's Median PS Value or its related term are showing as below:

XSWX:ROG' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.67   Med: 1.04   Max: 1.31
Current: 0.67

During the past 13 years, the highest Price to Median PS Value of Roche Holding AG was 1.31. The lowest was 0.67. And the median was 1.04.

XSWX:ROG's Price-to-Median-PS-Value is ranked better than
61.08% of 501 companies
in the Drug Manufacturers industry
Industry Median: 0.77 vs XSWX:ROG: 0.67

Roche Holding AG Median PS Value Historical Data

The historical data trend for Roche Holding AG's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roche Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 295.35 287.96 321.86 362.50 329.89

Roche Holding AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Median PS Value Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 321.86 - 362.50 - 329.89

Competitive Comparison

For the Drug Manufacturers - General subindustry, Roche Holding AG's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Roche Holding AG Price-to-Median-PS-Value Distribution

For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Roche Holding AG's Price-to-Median-PS-Value falls into.



Roche Holding AG Median PS Value Calculation

Roche Holding AG's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=75.176*4.3882
=329.89

10-Year Median PS Ratio is 4.3882.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Roche Holding AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was CHF75.176.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Roche Holding AG  (XSWX:ROG) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Roche Holding AG's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=220.00/329.89
=0.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Roche Holding AG Median PS Value Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Roche Holding AG (XSWX:ROG) Business Description

Address
Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

Roche Holding AG (XSWX:ROG) Headlines

From GuruFocus

Rogers Schedules First Quarter 2023 Earnings Call for April 27

By Business Wire Business Wire 04-13-2023

Rogers Announces Agreement with Starboard Value

By Business Wire Business Wire 02-27-2023

Rogers Announces Leadership Transition

By Business Wire Business Wire 11-17-2022

Rogers To Hold Investor Conference Call On December 8, 2022

By Business Wire Business Wire 11-28-2022

WESTPORT ASSET MANAGEMENT INC Buys 1, Sells 4 in 4th Quarter

By GuruFocus Research GuruFocus Editor 02-18-2023